L A Brown1, J L Krull1, P Roy-Byrne2, C D Sherbourne3, M B Stein4, G Sullivan5, R D Rose1, A Bystritsky6, M G Craske1. 1. Department of Psychology,University of California,Los Angeles,USA. 2. University of Washington at Harborview Medical Center,Center for Healthcare Improvement for Addictions,Mental Illness, andMedically Vulnerable Populations (CHAMMP),Seattle,WA,USA. 3. RAND Corporation,Santa Monica,CA,USA. 4. Department of Psychiatry and Department of Family & Preventive Medicine,University of California,San Diego,USA. 5. South Central VA Mental Illness Research Education and Clinical Center,North Little Rock,AK,USA. 6. Department of Psychiatry & Biobehavioral Sciences,University of California,Los Angeles,USA.
Abstract
BACKGROUND:Patients with anxiety disorders suffer marked functional impairment in their activities of daily living. Many studies have documented that improvements in anxiety symptom severity predict functioning improvements. However, no studies have investigated how improvements in functioning simultaneously predict symptom reduction. We hypothesized that symptom levels at a given time point will predict functioning at the subsequent time point, and simultaneously that functioning at a given time point will predict symptom levels at a subsequent time point. METHOD:Patients were recruited from primary-care centers for the Coordinated Anxiety Learning and Management (CALM) study and were randomized to receive either computer-assisted cognitive-behavioral therapy and/or medication management (ITV) or usual care (UC). A cross-lagged panel design examined the relationship between functional impairment and anxiety and depression symptom severity at baseline, 6-, 12-, and 18-month follow-up assessments. RESULTS: Prospective prediction of functioning from symptoms and symptoms from functioning were both important in modeling these associations. Anxiety and depression predicted functioning as strongly as functioning predicted anxiety and depression. There were some differences in these associations between UC and ITV. Where differences emerged, the UC group was best modeled with prospective paths predicting functioning from symptoms, whereas symptoms and functioning were both important predictors in the ITV group. CONCLUSIONS: Treatment outcome is best captured by measures of functional impairment as well as symptom severity. Implications for treatment are discussed, as well as future directions of research.
RCT Entities:
BACKGROUND:Patients with anxiety disorders suffer marked functional impairment in their activities of daily living. Many studies have documented that improvements in anxiety symptom severity predict functioning improvements. However, no studies have investigated how improvements in functioning simultaneously predict symptom reduction. We hypothesized that symptom levels at a given time point will predict functioning at the subsequent time point, and simultaneously that functioning at a given time point will predict symptom levels at a subsequent time point. METHOD:Patients were recruited from primary-care centers for the Coordinated Anxiety Learning and Management (CALM) study and were randomized to receive either computer-assisted cognitive-behavioral therapy and/or medication management (ITV) or usual care (UC). A cross-lagged panel design examined the relationship between functional impairment and anxiety and depression symptom severity at baseline, 6-, 12-, and 18-month follow-up assessments. RESULTS: Prospective prediction of functioning from symptoms and symptoms from functioning were both important in modeling these associations. Anxiety and depression predicted functioning as strongly as functioning predicted anxiety and depression. There were some differences in these associations between UC and ITV. Where differences emerged, the UC group was best modeled with prospective paths predicting functioning from symptoms, whereas symptoms and functioning were both important predictors in the ITV group. CONCLUSIONS: Treatment outcome is best captured by measures of functional impairment as well as symptom severity. Implications for treatment are discussed, as well as future directions of research.
Authors: Sally Chan; Shoumei Jia; Helen Chiu; Wai-Tong Chien; David R Thompson; Yan Hu; Linda Lam Journal: Int J Geriatr Psychiatry Date: 2009-04 Impact factor: 3.485
Authors: Benjamin B Lahey; Robert F Krueger; Paul J Rathouz; Irwin D Waldman; David H Zald Journal: Psychol Bull Date: 2016-12-22 Impact factor: 17.737
Authors: Lily A Brown; Emily Wakschal; Stefanie Russman-Block; Christina L Boisseau; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen Journal: J Affect Disord Date: 2018-11-13 Impact factor: 4.839
Authors: Lily A Brown; Gabriella E Hamlett; Yiqin Zhu; Joshua F Wiley; Tyler M Moore; Grace E DiDomenico; Elina Visoki; David M Greenberg; Ruben C Gur; Raquel E Gur; Ran Barzilay Journal: J Sleep Res Date: 2022-02-14 Impact factor: 5.296